<DOC>
	<DOC>NCT01104012</DOC>
	<brief_summary>The purpose of this study is to verify and validate the intrinsic diagnostic value in terms of sensitivity and specificity of proteomic profiles determined during a pre-study for discriminating between allergy related asthma and allergy related rhinitis.</brief_summary>
	<brief_title>Validation of Proteomic Analyses for Allergic Asthma and Rhinitis</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis, Allergic</mesh_term>
	<criteria>signed consent neversmokers or nonsmoking for at least 2 years + &lt; 5 packs per year capable of understanding the study patient is affiliated with a social security system positive skin tests (at least one for Montpellier region pneumoallergens) treated with nasal or inhaled corticoids, leucotriene receptor antagonists, antiIgE, Theophylline, antihistamines, sodium cromoglycate, betablockers, benzodiaz√©pine, oral corticoids: all these treatments must be interrupted for at least 72 hours Comorbidities: none; no comorbidities are accepted dental infections (any) during the 3 months preceding the study suspected alcoholism or drug abuse chronic viral infection (hepatitis, HIV) patient under guardianship</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>